Belgium

The AW Deal Watch started off the week strong with $978 million in private market activity. Apollo Global Management struck the largest deal by far with a $500 million convertible preferred stock purchase.

Our second daily edition of AW Deal Watch clocked in just shy of $1 billion in disclosed private market deals across private equity, credit, infrastructure and digital assets.

AW Research tracked about $2.3 billion in private market deals across credit, equity, infrastructure and real estate in the week ending March 10.

The fourth quarter marked a full year of decline in global venture capital investment, which is currently at a two-year low, according to KPMG’s latest Venture Pulse Report. Overall global venture capital investment dropped from $102 billion in Q3 to ...

Divided by asset class, Alternatives Watch tracked a total of roughly $5.6 billion in alternative investment deals announced in the week ending Oct. 28.

StepStone Real Estate, the $11 billion real estate arm of StepStone Group, hired Yasmine Uzmez as a managing director on its business development team in New York. She has been active in the real estate industry for nearly two decades. ...

PGIM Private Capital announced that it provided $10 billion of senior debt and junior capital to more than 140 middle market companies in the first half of this year. The record first half volume for the firm was global in ...

The $13 billion global private equity firm The Riverside Company has set up a shelter for Ukrainian civilians who urgently need a safe harbor through Alter Pharma, its Belgium-based pharmaceutical portfolio company. The shelter is located in a vacant office ...

Union Bancaire Privée (UBP) added a new ESG sovereign local-currency debt strategy focused on emerging markets that meets the requirements of the E.U.'s Sustainable Financial Disclosure Regulation (SFDR). UBAM-EM Sustainable Local Bond will seek to improve ESG factors by favoring ...

AXA Investment Managers has tracked significant interest in its new life science strategy that is said to be oversubscribed. The AXA European Life Science Fund is raising €750 million ($896 million) for a minority stake in ELSS, which is a ...